ARCHIVES

An “insurgency” targets randomized trials, demands access to investigational drugs.

This article is from The Cancer Letter archive.

Vol. 31 No. 31 | August 5, 2005

Download PDF Visit The Full Archive

Related Articles

High-Dose Chemo Doesn’t Improve Survival In Small Cell Lung Cancer

April 25, 2008

NCI Plans $61 Million For Six-Year Program In Biomarker Research For Early Detection

December 4, 1998

UICC Merit Award Winners Announced

September 19, 1986

Cholesterol-Lowering Drugs May Prevent Breast Cancer

October 31, 2003

Carcinogenesis Testing Moved Out of DCCP To New Status As Division, Giving Rall More Authority

September 14, 1979

Patients Advocates Develop Statement On Health Care Reform

March 12, 1993